Internet addiction in adolescents with suicidal ideation: the role of self-esteem and school connectedness
The Role of Disulfide Bonds in the GluN1 Subunit in the Early Trafficking and Functional Properties of GluN1/GluN2 and GluN1/GluN3 NMDA Receptors
N-Methyl-
Closing the Gap in Autism Genetics: Population-Specific Variants and the Imperative for Global Inclusion
Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental condition with an exceptionally complex and heterogeneous genetic architecture, encompassing both polygenic common variants and rare, high-impact variants. Over the past decade, large-scale sequencing studies in Europe and North America have identified hundreds of ASD risk genes and substantially advanced biological insight. However, the global distribution of ASD genomic research remains profoundly imbalanced, with most non-European ancestry populations severely underrepresented.
World Mental Health Day Statement
Ottawa – October 10, 2025
As someone who has worked in countries affected by conflict and humanitarian crises, I’ve learned that physical displacement is only part of the story. The mental and emotional toll defines the other half of that experience, and often for much longer.
This World Mental Health Day focuses on mental health in humanitarian emergencies. It asks us to consider not just the scale of the challenge, but the strength of the response possible when communities lead the way.
There is no single solution to the mental health impacts of humanitarian crises. But what I’ve witnessed, both internationally and here on Turtle Island, is that the most meaningful support often comes from within affected communities themselves.
Whether it’s refugees organizing healing circles in displacement camps, neighbours checking in on one another after a wildfire, or volunteers trained to provide peer support—these acts of care are not just helpful. They are essential. They save lives.
Right now, the world feels heavy. The growing phenomenon of eco-anxiety, combined with escalating crises of famine, war, and displacement, can make hope feel out of reach. We see the numbers—123 million people forcibly displaced worldwide—and it can be overwhelming.
But I’ve also seen what happens when we share that weight by leaning on one another. This is equally true for humanitarian aid workers, who are responding to unprecedented numbers of conflicts and urgencies at home and around the globe.
As the World Health Organization reminds us, “Humanitarian workers face extreme stress and are often directly affected by the crisis they respond to.”
As a member of this community, I know that sustaining an effective humanitarian response means meeting the needs of those providing comfort and care, whether through peer support, workplace health programs, or Mental Health First Aid. Here at home, programs like The Working Mind – First Responder are helping to create a culture of care for those we call on in crisis.
The way we heal—whether we’re first responders or community workers, volunteers or refugees—is through community. It’s in the everyday ways we show up for one another: listening without judgment, making space for grief and fear, and recognizing that asking for help is an act of courage.
On this World Mental Health Day, let’s all find the courage to lean on each other.
Lili-Anna Pereša C.Q.
President & CEO
Mental Health Commission of Canada
The post World Mental Health Day Statement appeared first on Mental Health Commission of Canada.
Canada Gets its First National Guidance on AI for Mental and Substance Use Health
Ottawa (ONTARIO) – In a first-of-its-kind initiative, national guidance for using artificial intelligence (AI) in the mental and substance use health field is being developed through a partnership between the Canadian Centre on Substance Use and Addiction (CCSA) and the Mental Health Commission of Canada.
AI is increasingly being used for healthcare triage, service navigation, service delivery, and communication, but developers and users have no guidelines specific to mental or substance use health to support its effective and safe use. The recently published E-Mental Health Strategy for Canada highlights the need for safety in this field.
The new National Guidance for Artificial Intelligence Use in Mental Health and Substance Use Health Care will provide guidance, tools, and resources to help practitioners, organizations, and health leaders in efficiently evaluating and implementing AI-enabled mental health and substance use health care services and solutions. It will also support people with lived or living experience of mental health or substance use health concerns in making informed choices about these technologies, while helping technology companies design and improve such solutions to meet the needs of those who use them.
“People are excited about what AI can bring, but the saying ‘break it then fix it’ can take on new dangers when what is at risk is people’s lives. This guidance will allow innovators to move fast while working to ensure it’s done safely and in a way that increases impact and access,” says CCSA CEO Dr. Alexander Caudarella.
The Mental Health Commission of Canada President and CEO Lili-Anna Pereša adds, “Technology can be a powerful ally in transforming mental health care, but innovation must be matched with responsibility. Communities are the best problem-solvers. By working together with developers, providers, and people with lived experience, we’re creating guidance that ensures AI enhances care safely and meaningfully.”
The National Guidance team will share its early findings at several upcoming conferences, including the World Psychiatric Association’s World Congress of Psychiatry, the Canadian Centre on Substance Use and Addiction’s Issues of Substance conference, and the eMental Health International Collaborative (eMHIC) Congress.
In Canada, mental health and substance use health needs are highly common, yet many people continue to face significant barriers to care, including limited access, stigma, financial costs, and lack of tailored treatment options.
The National Guidance for Artificial Intelligence Use with Mental Health and Substance Use Health is expected to launch in 2026/2027.
-30-
About CCSA:
CCSA was created by Parliament to provide national leadership to address substance use in Canada. A trusted counsel, we provide national guidance to decision makers by harnessing the power of research, curating knowledge and bringing together diverse perspectives. CCSA activities and products are made possible through a financial contribution from Health Canada. The views of CCSA do not necessarily represent the views of Health Canada.
About The Mental Health Commission of Canada:
The Commission leads the development and dissemination of innovative programs and tools to support the mental health and wellness of people in Canada. Through its unique mandate from the Government of Canada, the Commission supports federal, provincial, and territorial governments as well as organizations in the implementation of sound public policy. The Commission’s current mandate aims to deliver on priority areas identified in the Mental Health Strategy for Canada in alignment with the delivery of its strategic plan.
Media contacts:
Canadian Centre on Substance Use and Addiction
Christine LeBlanc, Senior Strategic Communications Advisor
613-898-6343 | cleblanc@ccsa.ca
Mental Health Commission of Canada
media@mentalhealthcommission.ca
The post Canada Gets its First National Guidance on AI for Mental and Substance Use Health appeared first on Mental Health Commission of Canada.
Beyond Survival: Addressing the Mental Health Crisis Among the World’s Displaced
The post Beyond Survival: Addressing the Mental Health Crisis Among the World’s Displaced appeared first on Mental Health Commission of Canada.
Hertfordshire Community NHS Trust to roll out AI-scribing
Development of the Healthy Women Intervention to Increase Women’s Engagement in Medication Treatment for Opioid Use Disorder: Mixed Methods, User-Centered Design Approach
Background: Rates of opioid use disorder (OUD) have increased among women over the past 2 decades. Medication treatment for opioid use disorder (MOUD) is effective but underused. Gender-specific treatments for women have been associated with improved substance use outcomes. However, these treatments have not specifically targeted women’s engagement in MOUD, and the impact of existing gender-specific treatments is restricted by in-person delivery. Objective: The aim of this study was to develop a digital intervention to feasibly deliver gender-specific care that addresses the individualized needs of women with OUD to increase engagement in MOUD. Methods: A mixed methods, user-centered design approach was used to inform the development of a digital intervention. In phase 1, qualitative interviews were conducted with women with lived experience of OUD (n=20) and providers who treat women with OUD (n=8). Interviews were recorded, transcribed, and coded for themes. In addition, a larger sample of treatment providers (n=55) completed an online survey to further inform the content of the digital intervention. Phase 2 consisted of designing, beta-testing (n=5), and refining the intervention. Results: The age of women with lived experience ranged from 21 to 59 (mean 38.5, SD 9.4) years; 63% (5/8) of providers interviewed were female participants. The qualitative interview data from women with lived experience and providers were grouped into 6 thematic categories: 3 treatment-related (1) barriers to treatment, (2) facilitators to successful recovery, and (3) important issues to address in treatment, and 3 technology-related (4) positives of using technology as part of treatment, (5) suggested technology features, and (6) barriers to using technology. Across the treatment-related categories, several themes touched on women-specific factors including family responsibilities, abusive partners, stigma, and motivation for treatment (eg, pregnancy). The technology-related categories provided information for designing the features of the intervention, as well as revealing barriers to technology use, which could be helpful in developing implementation strategies. Provider survey participants were primarily female participants (40/55, 73%), with a mean age of 42.5 (SD 12.5) years. Survey data provided additional information on barriers to treatment and suggested technology features. Based on these data and preliminary work, the intervention was created. Minor edits to content and visual design were made in the beta-testing phase. The final version includes a web-based component with 6 topic modules and a mobile component. Topics in the web-based component are presented through infographics, text, videos, and interactive questions. The mobile component includes daily motivational messages, skills practice activities (2/wk), weekly check-ins, and resources (always available). Conclusions: Important themes and suggested features from women with lived experience and providers were incorporated into a digital intervention for women with OUD. Data on feasibility, satisfaction, and engagement with the intervention are currently being collected in phase 3, a pilot randomized controlled trial.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/6b8c4ff957e61601e8e82fd621767c3d" />

